Gurrola Sandra M — SEC Form 4 filings

SEC reporting owner CIK 1618457. 4 Form 4 filings on record with FilingPulse; latest filed 2025-07-07.

Transaction summary — filings shown

Covers all 4 filings on record, filed 2024-04-29 to 2025-07-07. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Ernexa Therapeutics Inc. (ERNA)Sr. VP of Finance47

Form 4 filings — Gurrola Sandra M

FiledFormIssuerReported transactionsSource
2025-07-074Ernexa Therapeutics Inc. (ERNA)Option exercise (M): 30 · Option exercise (M): 30 (derivative) @ $0EDGAR
2025-02-104Eterna Therapeutics Inc. (ERNA)Grant/award (A): 150,000 (derivative) @ $0EDGAR
2024-06-254Eterna Therapeutics Inc. (ERNA)Option exercise (M): 437 · Tax withholding (F): 180 @ $1.94 · Option exercise (M): 437 (derivative) @ $0EDGAR
2024-04-294Eterna Therapeutics Inc. (ERNA)Grant/award (A): 80,000 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1618457 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →